2-[(3R,4S,8S,10S,11R,14S,16S)-16-Acetoxy-3,11-dihydroxy-4,8,10,14-tetramethyl-hexadecahydro-cyclopenta[a]phenanthren-(17Z)-ylidene]-6-methyl-hept-5-enoic acid

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: 2-[(3R,4S,8S,10S,11R,14S,16S)-16-Acetoxy-3,11-dihydroxy-4,8,10,14-tetramethyl-hexadecahydro-cyclopenta[a]phenanthren-(17Z)-ylidene]-6-methyl-hept-5-enoic acid
• 英文别名: (2Z)-2-[(3R,4S,8S,10S,11R,14S,16S)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoic acid
• 化学式: C₃₁H₄₈O₆
• 分子量: 516.719
• InChiKey: IECPWNUMDGFDKC-ZUARWYTBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.5
• 重原子数：
  37
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.81
• 拓扑面积：
  104
• 氢给体数：
  3
• 氢受体数：
  6

文献信息

• Novel fusidic acid derivatives
  申请人：Duvold Tore

  公开号：US20070105826A1

  公开（公告）日：2007-05-10

  Fusidic acid derivatives substituted at C-24 may be used in therapy for the treatment of infections.